Completed × Has results × Radiotherapy, Intensity-Modulated × Clear all Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
Phase 1/2 Completed
22 enrolled 13 charts
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
Phase 2 Completed
106 enrolled 12 charts
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
Phase 2/3 Completed
418 enrolled 52 charts
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Phase 3 Completed
546 enrolled 29 charts
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy
Phase 2 Completed
67 enrolled 16 charts
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Phase 2 Completed
81 enrolled 18 charts
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Phase 2/3 Completed
196 enrolled 31 charts
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Phase 1 Completed
99 enrolled 11 charts
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Phase 3 Completed
987 enrolled 59 charts
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Phase 3 Completed
236 enrolled 28 charts
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
Phase 1 Completed
23 enrolled 11 charts
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Phase 2 Completed
363 enrolled 16 charts
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase 2 Completed
262 enrolled 17 charts
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Phase 2 Completed
91 enrolled 14 charts
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Completed
170 enrolled 19 charts
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
Phase 3 Completed
340 enrolled 13 charts
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Phase 3 Completed
518 enrolled 40 charts
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
10 enrolled 13 charts
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Phase 2 Completed
38 enrolled 13 charts
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
Phase NA Completed
20 enrolled 8 charts
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
Phase 2 Completed
115 enrolled 18 charts
APA
Phase 2 Completed
96 enrolled 34 charts
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
Phase 2/3 Completed
101 enrolled 13 charts
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
Phase 2 Completed
45 enrolled 22 charts
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Phase 2 Completed
29 enrolled 27 charts
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Phase NA Completed
83 enrolled 7 charts
Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer
Phase 2 Completed
62 enrolled 15 charts
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Phase 2 Completed
195 enrolled 19 charts
PAINT
Phase 2 Completed
35 enrolled 13 charts
CORRECT
Phase 2 Completed
9 enrolled 9 charts
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Phase 2 Completed
244 enrolled 15 charts
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Completed
20 enrolled 17 charts
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
320 enrolled 13 charts
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Phase 2 Completed
21 enrolled 10 charts
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
Phase 3 Completed
1,534 enrolled 14 charts
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Phase 2 Completed
182 enrolled 19 charts
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
Phase 2 Completed
38 enrolled 10 charts
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Phase 2 Completed
261 enrolled 10 charts
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Phase 3 Completed
612 enrolled 11 charts
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
940 enrolled 19 charts
INFIELD
Phase 2 Completed
72 enrolled 14 charts
Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Phase 1/2 Completed
79 enrolled 17 charts
Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc
Phase NA Completed
22 enrolled 10 charts
A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer
Phase NA Completed
25 enrolled 4 charts
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Completed
37 enrolled 6 charts
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
37 enrolled 9 charts
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Phase 1/2 Completed
39 enrolled 8 charts
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Completed
20 enrolled 17 charts
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Phase 2 Completed
3 enrolled 7 charts